These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

322 related articles for article (PubMed ID: 16403952)

  • 1. The Gly482Ser missense mutation of the peroxisome proliferator-activated receptor gamma coactivator-1 alpha (PGC-1 alpha) gene associates with reduced insulin sensitivity in normal and glucose-intolerant obese subjects.
    Fanelli M; Filippi E; Sentinelli F; Romeo S; Fallarino M; Buzzetti R; Leonetti F; Baroni MG
    Dis Markers; 2005; 21(4):175-80. PubMed ID: 16403952
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Studies of the Gly482Ser polymorphism of the peroxisome proliferator-activated receptor gamma coactivator 1alpha (PGC-1alpha) gene in Danish subjects with the metabolic syndrome.
    Ambye L; Rasmussen S; Fenger M; Jørgensen T; Borch-Johnsen K; Madsbad S; Urhammer SA
    Diabetes Res Clin Pract; 2005 Feb; 67(2):175-9. PubMed ID: 15649578
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Common polymorphisms of the PPAR-gamma2 (Pro12Ala) and PGC-1alpha (Gly482Ser) genes are associated with the conversion from impaired glucose tolerance to type 2 diabetes in the STOP-NIDDM trial.
    Andrulionytè L; Zacharova J; Chiasson JL; Laakso M;
    Diabetologia; 2004 Dec; 47(12):2176-84. PubMed ID: 15592662
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Single nucleotide polymorphisms of PPARD in combination with the Gly482Ser substitution of PGC-1A and the Pro12Ala substitution of PPARG2 predict the conversion from impaired glucose tolerance to type 2 diabetes: the STOP-NIDDM trial.
    Andrulionyte L; Peltola P; Chiasson JL; Laakso M;
    Diabetes; 2006 Jul; 55(7):2148-52. PubMed ID: 16804087
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PGC-1alpha Gly482Ser polymorphism is associated with the plasma adiponectin level in type 2 diabetic men.
    Okauchi Y; Iwahashi H; Okita K; Yuan M; Matsuda M; Tanaka T; Miyagawa J; Funahashi T; Horikawa Y; Shimomura I; Yamagata K
    Endocr J; 2008 Dec; 55(6):991-7. PubMed ID: 18614852
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Gly482Ser polymorphism of the coactivator-1alpha of the activated receptor of peroxisome gamma proliferation in individuals from Maracaibo, Venezuela].
    Zambrano M; Fernández E; López M; Rangel A; de Romero P; Fernández V; Marina Morales L; Molero-Conejo E; Connell L; Raleigh X; Aranguren-Mendez J
    Invest Clin; 2009 Sep; 50(3):285-94. PubMed ID: 19961051
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impaired coactivator activity of the Gly482 variant of peroxisome proliferator-activated receptor gamma coactivator-1alpha (PGC-1alpha) on mitochondrial transcription factor A (Tfam) promoter.
    Choi YS; Hong JM; Lim S; Ko KS; Pak YK
    Biochem Biophys Res Commun; 2006 Jun; 344(3):708-12. PubMed ID: 16631115
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhanced short-term improvement of insulin response to a low-caloric diet in obese carriers the Gly482Ser variant of the PGC-1alpha gene.
    Goyenechea E; Crujeiras AB; Abete I; Parra D; Martínez JA
    Diabetes Res Clin Pract; 2008 Nov; 82(2):190-6. PubMed ID: 18823672
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Linking Metabolic Disease With the PGC-1α Gly482Ser Polymorphism.
    Vandenbeek R; Khan NP; Estall JL
    Endocrinology; 2018 Feb; 159(2):853-865. PubMed ID: 29186342
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gene expression of PPARgamma and PGC-1alpha in human omental and subcutaneous adipose tissues is related to insulin resistance markers and mediates beneficial effects of physical training.
    Ruschke K; Fishbein L; Dietrich A; Klöting N; Tönjes A; Oberbach A; Fasshauer M; Jenkner J; Schön MR; Stumvoll M; Blüher M; Mantzoros CS
    Eur J Endocrinol; 2010 Mar; 162(3):515-23. PubMed ID: 19966034
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association between peroxisome proliferator-activated receptor-gamma coactivator-1alpha gene polymorphisms and type 2 diabetes in southern Chinese population: role of altered interaction with myocyte enhancer factor 2C.
    Zhang SL; Lu WS; Yan L; Wu MC; Xu MT; Chen LH; Cheng H
    Chin Med J (Engl); 2007 Nov; 120(21):1878-85. PubMed ID: 18067759
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Peroxisome proliferator-activated receptor-gamma and its coactivator-1alpha gene polymorphisms in Korean women with polycystic ovary syndrome.
    Chae SJ; Kim JJ; Choi YM; Kim JM; Cho YM; Moon SY
    Gynecol Obstet Invest; 2010; 70(1):1-7. PubMed ID: 20130411
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Gly482Ser polymorphism of the peroxisome proliferator-activated receptor-γ coactivator-1α (PGC-1α) is associated with type 2 diabetes in Tunisian population.
    Jemaa Z; Kallel A; Sleimi C; Mahjoubi I; Feki M; Ftouhi B; Slimane H; Jemaa R; Kaabachi N
    Diabetes Metab Syndr; 2015; 9(4):316-9. PubMed ID: 25470625
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of PGC-1alpha variants Gly482Ser and Thr612Met concerning their PPARgamma2-coactivation function.
    Nitz I; Ewert A; Klapper M; Döring F
    Biochem Biophys Res Commun; 2007 Feb; 353(2):481-6. PubMed ID: 17187763
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of the peroxisome proliferator activated receptor-γ coactivator-1α (PGC-1α) Thr394Thr and Gly482Ser polymorphisms on rosiglitazone response in Chinese patients with type 2 diabetes mellitus.
    Zhang KH; Huang Q; Dai XP; Yin JY; Zhang W; Zhou G; Zhou HH; Liu ZQ
    J Clin Pharmacol; 2010 Sep; 50(9):1022-30. PubMed ID: 20498286
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Energy-sensing factors coactivator peroxisome proliferator-activated receptor γ coactivator 1-α (PGC-1α) and AMP-activated protein kinase control expression of inflammatory mediators in liver: induction of interleukin 1 receptor antagonist.
    Buler M; Aatsinki SM; Skoumal R; Komka Z; Tóth M; Kerkelä R; Georgiadi A; Kersten S; Hakkola J
    J Biol Chem; 2012 Jan; 287(3):1847-60. PubMed ID: 22117073
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gly482Ser mutation impairs the effects of peroxisome proliferator-activated receptor γ coactivator-1α on decreasing fat deposition and stimulating phosphoenolpyruvate carboxykinase expression in hepatocytes.
    Chen Y; Mu P; He S; Tang X; Guo X; Li H; Xu H; Woo SL; Qian X; Zeng L; Wu C
    Nutr Res; 2013 Apr; 33(4):332-9. PubMed ID: 23602251
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Gly482Ser missense mutation in the peroxisome proliferator-activated receptor gamma coactivator-1 is associated with altered lipid oxidation and early insulin secretion in Pima Indians.
    Muller YL; Bogardus C; Pedersen O; Baier L
    Diabetes; 2003 Mar; 52(3):895-8. PubMed ID: 12606537
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The peroxisome proliferator-activated receptor gamma coactivator-1 alpha gene (PGC-1alpha) is not associated with type 2 diabetes mellitus or body mass index among Hispanic and non Hispanic Whites from Colorado.
    Nelson TL; Fingerlin TE; Moss L; Barmada MM; Ferrell RE; Norris JM
    Exp Clin Endocrinol Diabetes; 2007 Apr; 115(4):268-75. PubMed ID: 17479445
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evidence for interaction between PPARG Pro12Ala and PPARGC1A Gly482Ser polymorphisms in determining type 2 diabetes intermediate phenotypes in overweight subjects.
    Ruchat SM; Weisnagel SJ; Vohl MC; Rankinen T; Bouchard C; Pérusse L
    Exp Clin Endocrinol Diabetes; 2009 Oct; 117(9):455-9. PubMed ID: 19536736
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.